The Texas-based company, known for its focus on dermatologic and gastroenterological diagnostics, will publish its data after the market closes. Following the report, leadership will hold a conference call at 4:30 p.m. Eastern time to discuss the quarterly outcomes.

Participants can join the session via the company’s investor relations portal or the provided webcast link, with organizers recommending arrival at least 10 minutes early. The presentation will include a dedicated question-and-answer period, and a replay will be made available shortly after the event concludes.